Clinical Trials Directory

Trials / Completed

CompletedNCT06429514

Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression

Based on the Theory of Gut-brain Axis, the Intervention Effect and Related Mechanism of Ganoderma Lucidum Spore Powder on Depressive Symptoms in Patients With Thyroid Cancer Were Investigated

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
298 (actual)
Sponsor
Ling Zhiqiang · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.

Detailed description

After being informed of the study and potential risks, all patients who gave written informed consent were enrolled. A total of 300 eligible patients were randomly assigned in a double-blind manner and divided into experimental group and control group at a ratio of 2 : 1. The subjects were given oral test drugs ( Ganoderma lucidum spore powder or placebo ) 4g per day for 90 days from the first day after enrollment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGanoderma lucidum spore powderOne bag at a time, 2 times a day, 2g / bag
OTHERplaceboOne bag at a time, 2 times a day, 2g / bag

Timeline

Start date
2023-03-28
Primary completion
2024-05-03
Completion
2024-05-03
First posted
2024-05-28
Last updated
2024-05-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06429514. Inclusion in this directory is not an endorsement.